BASF Agricultural Solutions introduces Nemasphere, a groundbreaking innovation in soybean cyst nematode (SCN) management
Soybean cyst nematode (SCN) is the number one yield-robbing pest in soybeans in the US, costing growers an estimated US$1.5bn in yield annually. Moreover, the effectiveness of native SCN traits is declining significantly.
After decades of longing for a solution to protect their fields from SCN, farmers have finally received Nemasphere, a tool to go on offense against this invisible threat.
Nemasphere, which will be stacked with the Enlist E3 technology, will produce a novel Cry14 protein that is ingested by nematodes. This protein will interfere with nutrient uptake in their intestines, thus leading to the nematodes’ death.
Nemasphere will be available in a full range of the top-performing and best-yielding soybean seed varieties, allowing farmers unmatched SCN resistance without compromising yield potential. Research trials have shown that Nemasphere on average, boosts yield potential by 8%.
With increasing SCN resistance to native traits, the yield gap tends to widen every year. In such cases, the boost Nemasphere delivers in bushels will be critical to help growers hit their full harvest potential and make it possible to achieve full genetic yield potential.
Nemasphere is currently pending regulatory approval and is anticipated to be available in 2028.
For more information, visit: www.agriculture.basf.com
BASF unveils groundbreaking innovation in SCN management
Nemasphere is currently pending regulatory approval and is anticipated to be available in 2028. (Image source: BASF)
